000 | 01138 a2200337 4500 | ||
---|---|---|---|
005 | 20250515031439.0 | ||
264 | 0 | _c20070808 | |
008 | 200708s 0 0 ger d | ||
022 | _a0020-9554 | ||
024 | 7 |
_a10.1007/s00108-006-1622-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHiddemann, W | |
245 | 0 | 0 |
_a[Risk-adapted therapy of acute myeloid leukemia]. _h[electronic resource] |
260 |
_bDer Internist _cJun 2006 |
||
300 |
_aS33-9 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xclassification |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aSpiekermann, K | |
700 | 1 | _aBraess, J | |
700 | 1 | _aFeuring-Buske, M | |
700 | 1 | _aBuske, C | |
700 | 1 | _aBüchner, T | |
773 | 0 |
_tDer Internist _gvol. 47 Suppl 1 _gp. S33-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00108-006-1622-y _zAvailable from publisher's website |
999 |
_c16368345 _d16368345 |